Do congenital bleeding disorders have a protective effect against COVID-19? A prospective study

Int J Lab Hematol. 2021 Jun;43(3):e124-e127. doi: 10.1111/ijlh.13413. Epub 2020 Nov 30.
No abstract available

Keywords: COVID-19; SARS-CoV-2; congenital bleeding disorders; hypercoagulability; hypocoagulability.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Blood Coagulation Disorders, Inherited / blood*
  • Blood Coagulation Disorders, Inherited / complications
  • Blood Coagulation Disorders, Inherited / drug therapy
  • Blood Coagulation Factors / therapeutic use
  • COVID-19 / blood*
  • COVID-19 / complications
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Iran / epidemiology
  • Male
  • Middle Aged
  • Prospective Studies
  • SARS-CoV-2*
  • Thrombosis / epidemiology
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Young Adult

Substances

  • Blood Coagulation Factors